The fitness of antimony-resistant Leishmania parasites: lessons from the field
- 1 April 2011
- journal article
- Published by Elsevier in Trends in Parasitology
- Vol. 27 (4) , 141-142
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani StrainsPLOS ONE, 2010
- Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-α productionBMC Infectious Diseases, 2010
- Demonstration of Genetic Exchange During Cyclical Development of Leishmania in the Sand Fly VectorScience, 2009
- Drug policy for visceral leishmaniasis: a cost‐effectiveness analysisTropical Medicine & International Health, 2007
- American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility?The Journal of Infectious Diseases, 2006
- The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosisScience, 2006
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLOS Medicine, 2006
- Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areasActa Tropica, 2001
- In Vitro Growth of Leishmania amazonensis Promastigotes Resistant to Pentamidine Is Dependent on Interactions among StrainsAntimicrobial Agents and Chemotherapy, 2001
- Clonality in LeishmaniaParasitology Today, 1993